Home Treatment for Individuals Suffering From Severe Addictive Disorders
A Pilot Study on Home Treatment for Individuals Suffering From Severe Addictive Disorders
1 other identifier
interventional
40
1 country
1
Brief Summary
Home Treatment (HT) has been successfully implemented in adult psychiatry in several countries including Switzerland. Patients with addiction problems were generally excluded even if the latter was not the main diagnosis. On the other hand, community treatments have successfully been established for these individuals. The investigators have recently offered HT to persons with severe addictive disorders which was well accepted. The investigators intend to conduct a pilot study to prepare a large-scale study if successful. The investigators intend to compare HT to treatment as usual (regular inpatient treatment) on a specialized ward with respect to readmission rates during 6 months after discharge. The data show that 70.8% of all readmissions occur during the first 6 months. Therefore, a period of 6 months is considered an adequate time interval to sufficiently answer this pilot study's question.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 23, 2022
CompletedFirst Posted
Study publicly available on registry
October 3, 2022
CompletedStudy Start
First participant enrolled
December 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2026
ExpectedAugust 28, 2025
August 1, 2025
3.1 years
September 23, 2022
August 21, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
readmission rates
Number of readmissions to hospital during the 6 months following discharge
6 month post-discharge
Secondary Outcomes (5)
time to readmission
6 months
length of hospitalization
6 months
number of emergency room visits
6 months
clinical outcome
6 months
patient satisfaction
6 months
Study Arms (2)
Home treatment
EXPERIMENTALHome visits by care staff at the same frequency as in hospital
Standard inpatient treatment
ACTIVE COMPARATORInpatient treatment on hospital ward
Interventions
Hospital-like treatment in patients' home. Caregivers, medical doctors and social workers will make several visits per day to the patients' home. 24/7 contact is available.
Eligibility Criteria
You may qualify if:
- Substance use disorder
- age 18 or above
- sufficient french language skills
- competent subjects
- consent to randomization progress
You may not qualify if:
- organic brain disease or developmental disorder
- non voluntary admission
- severe somatic comorbidity
- History of complicated substance withdrawal
- acute suicidal ideation
- aggressive behavior
- acute psychiatric disease such as mania or psychosis
- distance to center (must be reachable within 60 minutes)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Geneva University Hospital
Geneva, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
September 23, 2022
First Posted
October 3, 2022
Study Start
December 1, 2022
Primary Completion
December 31, 2025
Study Completion (Estimated)
May 31, 2026
Last Updated
August 28, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share